The BioPharm Brief: Advancing Parkinson, Kidney, Obesity and Cancer Care

Oct 06, 09:05 PM
Headliner
Share
Subscribe

Welcome to The BioPharm Brief, your daily snapshot of the latest developments shaping biopharmaceutical research, clinical progress, and therapeutic strategy. Today’s update looks at a potential Parkinson disease therapy moving toward clinical development, a new rare-disease partnership, flexible dosing strategies for obesity, and promising frontline lymphoma data.

Share
Subscribe
Next
The BioPharm Brief: Obesity Data and Manufacturing Shape Drug Progress
Top episodes
The BioPharm Brief: Early Design Risks, Oncology Signals, and a Biosimilars Power Move
by The BioPharm Brief
The BioPharm Brief: Cancer, Personalized
by The BioPharm Brief
The BioPharm Brief: What’s the Big Deal About Multispecific T-Cell Engagers in Cancer and Autoimmune Diseases?
by The BioPharm Brief